Walleye Trading’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-16,078
| Closed | -$79.1K | – | 2205 |
|
|
2024
Q1 | $79.1K | Sell |
16,078
-26,694
| -62% | -$131K | ﹤0.01% | 1058 |
|
|
2023
Q4 | $376K | Buy |
42,772
+30,190
| +240% | +$265K | ﹤0.01% | 915 |
|
|
2023
Q3 | $144K | Buy |
12,582
+12,475
| +11,659% | +$143K | ﹤0.01% | 1063 |
|
|
2023
Q2 | $2.71K | Sell |
107
-13,345
| -99% | -$338K | ﹤0.01% | 1254 |
|
|
2023
Q1 | $433K | Sell |
13,452
-14,631
| -52% | -$471K | ﹤0.01% | 627 |
|
|
2022
Q4 | $518K | Sell |
28,083
-77,605
| -73% | -$1.43M | ﹤0.01% | 670 |
|
|
2022
Q3 | $2.85M | Buy |
105,688
+68,890
| +187% | +$1.86M | 0.01% | 211 |
|
|
2022
Q2 | $509K | Sell |
36,798
-60,402
| -62% | -$835K | ﹤0.01% | 738 |
|
|
2022
Q1 | $1.9M | Buy |
97,200
+84,480
| +664% | +$1.65M | 0.01% | 304 |
|
|
2021
Q4 | $208K | Buy |
+12,720
| New | +$208K | ﹤0.01% | 1207 |
|
|
2021
Q3 | – | Sell |
-9,991
| Closed | -$296K | – | 2619 |
|
|
2021
Q2 | $296K | Buy |
+9,991
| New | +$296K | ﹤0.01% | 969 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 2374 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2170 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2029 |
|
|
2018
Q4 | – | Sell |
-21,501
| Closed | -$534K | – | 2266 |
|
|
2018
Q3 | $534K | Buy |
21,501
+6,562
| +44% | +$163K | ﹤0.01% | 751 |
|
|
2018
Q2 | $410K | Buy |
+14,939
| New | +$410K | ﹤0.01% | 788 |
|
|
2016
Q1 | – | Sell |
-4
| Closed | – | – | 2623 |
|
|
2015
Q4 | $0 | Buy |
+4
| New | – | ﹤0.01% | 2645 |
|
|
2015
Q3 | – | Sell |
-300
| Closed | -$10K | – | 2577 |
|
|
2015
Q2 | $10K | Buy |
+300
| New | +$10K | ﹤0.01% | 1307 |
|